Latest News

The safety profile of vepdegestrant in ER–positive/HER2– breast cancer was consistent with its observed profile in previous studies.
Vepdegestrant Meets PFS Primary End Point in ESR1m ER+/HER2– Breast Cancer

March 12th 2025

The safety profile of vepdegestrant in ER–positive/HER2– breast cancer was consistent with its observed profile in previous studies.

The Rapid Evolution of Cardiotoxicity in Breast Cancer and Why More Data is Needed
The Rapid Evolution of Cardiotoxicity in Breast Cancer and Why More Data is Needed

March 11th 2025

Sexual Health Considerations to Improve Survivorship in Breast Cancer
Sexual Health Considerations to Improve Survivorship in Breast Cancer

March 11th 2025

The test led to a modification in treatment plan for 48.1% of those with stage I to III HER2-positive breast cancer, 73.5% of which were reductions.
Genomic Assay Yields Strong Predictive Accuracy in HER2+ Breast Cancer

March 11th 2025

Breast MRI in patients with newly diagnosed breast cancer increased mastectomy rates and biopsy needs.
Preoperative Breast MRI Does Not Improve Surgical Plan/Local Control

March 10th 2025

More News